SelectQuote (SLQT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for November 11, 2025, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by November 10, 2025.
Voting matters and shareholder proposals
Election of two Class III director nominees, Donald L. Hawks III and Denise L. Devine, for three-year terms.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending June 30, 2026.
Advisory vote on executive compensation for named executive officers.
Proxy holders authorized to vote on other business arising at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from SelectQuote
- Revenue up 12% to $537.1M, net income $69.3M, and guidance cut by $40M amid external headwinds.SLQT
Q2 20265 Feb 2026 - FY2024 revenue and EBITDA beat guidance; 2025 growth limited by capital, but outlook strong.SLQT
Q4 202420 Jan 2026 - Revenue up 26% with strong pharmacy growth; $100M securitization boosts capital flexibility.SLQT
Q1 202517 Jan 2026 - Q2 revenue up 19% to $481.1M, net income $53.2M, $350M equity investment secured.SLQT
Q2 202523 Dec 2025 - All proposals passed, including director elections and auditor ratification, with no shareholder questions.SLQT
AGM 202516 Dec 2025 - Board recommends approval of all 2025 meeting proposals, emphasizing performance and governance.SLQT
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, highlighting governance and pay-for-performance.SLQT
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.SLQT
Proxy Filing1 Dec 2025 - Q3 FY2025 revenue up 8% to $408.2M; SelectRx and Life growth offset Senior declines.SLQT
Q3 202526 Nov 2025